Synthesis and Biological Evaluation of Novel 2-Arylalkylthio-5-iodine-6-substituted-benzyl-pyrimidine-4(3H)-ones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

被引：10

作者：

Zhang, Liang ^{[1
]}

Tang, Xiaowan ^{[1
]}

Cao, Yuanyuan ^{[1
]}

Wu, Shaotong ^{[1
]}

Zhang, Yu ^{[1
]}

Zhao, Jianxiong ^{[1
]}

Guo, Ying ^{[1
]}

Tian, Chao ^{[1
]}

Zhang, Zhili ^{[1
]}

Liu, Junyi ^{[1
,2
]}

Wang, Xiaowei ^{[1
]}

机构：

[1] Peking Univ, Dept Biol Chem, Sch Pharmaceut Sci, Beijing 100191, Peoples R China

[2] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China

来源：

MOLECULES | 2014年 / 19卷 / 06期

关键词：

HIV; NNRTIs; S-DABOs; IC50; docking; IMMUNODEFICIENCY-VIRUS TYPE-1; S-DABO DERIVATIVES; ANTI-HIV-1; ACTIVITY; URACIL DERIVATIVES; IN-VITRO; DESIGN; RESISTANCE; DRUGS;

D O I：

10.3390/molecules19067104

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A novel series of 2-arylalkylthio-5-iodine-6-substitutedbenzyl-pyrimidine-4(3H)-ones (S-DABOs) 8a-x had been synthesized via an efficient method. Their biological activity against HIV virus and RT assay were evaluated. Some compounds, especially 8h, 8l and 8n, displayed promising activity against HIV-1 RT with IC50 values in a range of 0.41 mu M to 0.71 mu M, which were much better than that of nevirapine. Molecular modeling studies revealed that the binding mode would be affected via forming an additional hydrogen bond by incorporating an oxygen atom on the C-2 side chain. The biological activity was in accordance with the docking results.

引用

页码：7104 / 7121

页数：18

共 28 条

[1] 3,4-DIHYDRO-2-ALKOXY-6-BENZYL-4-OXOPYRIMIDINES (DABOS) - A NEW CLASS OF SPECIFIC INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
ARTICO, M
MASSA, S
MAI, A
MARONGIU, ME
PIRAS, G
TRAMONTANO, E
LACOLLA, P
[J]. ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1993, 4 (06) : 361 - 368
[2] CERIUM(IV)-MEDIATED HALOGENATION AT C-5 OF URACIL DERIVATIVES
ASAKURA, J
ROBINS, MJ
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1990, 55 (16) : 4928 - 4933
[3] DANEL K, 1995, SYNTHESIS-STUTTGART, P934
[4] Crystallography and the design of anti-AIDS drugs: Conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors
Das, K
Lewi, PJ
Hughes, SH
Arnold, E
[J]. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2005, 88 (02) : 209 - 231
[5] THE STRUCTURE OF MELDRUMS SUPPOSED BETA-LACTONIC ACID
DAVIDSON, D
BERNHARD, SA
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1948, 70 (10) : 3426 - 3428
[6] Non-nucleoside reverse transcriptase inhibitors (NNRTIs): Past, present, and future
De Clercq, E
[J]. CHEMISTRY & BIODIVERSITY, 2004, 1 (01) : 44 - 64
[7] Models which explain the inhibition of reverse transcriptase by HIV-1-specific (thio)carboxanilide derivatives
Esnouf, RM
Stuart, DI
DeClercq, E
Schwartz, E
Balzarini, J
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 234 (02) : 458 - 464
[8] Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents
He, Yan-Ping
Long, Jin
Zhang, Shui-Shuan
Li, Cong
Lai, Christopher Cong
Zhang, Chun-Sheng
Li, Da-Xiong
Zhang, De-Hua
Wang, Hua
Cai, Qing-Qing
Zheng, Yong-Tang
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (02) : 694 - 697
[9] CRYSTAL-STRUCTURE AT 3.5 ANGSTROM RESOLUTION OF HIV-1 REVERSE-TRANSCRIPTASE COMPLEXED WITH AN INHIBITOR
KOHLSTAEDT, LA
WANG, J
FRIEDMAN, JM
RICE, PA
STEITZ, TA
[J]. SCIENCE, 1992, 256 (5065) : 1783 - 1790
[10] The design and synthesis of N-1-alkylated-5-aminoaryalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors
Lu, Xiao
Chen, Yanli
Guo, Ying
Liu, Zhenming
Shi, Yawei
Xu, Yang
Wang, Xiaowei
Zhang, Zhili
Liu, Junyi
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (23) : 7399 - 7407

← 1 2 3 →